STOCK TITAN

ObsEva Files half Year 2023 Financial Statements

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
ObsEva SA has published its Half Year 2023 Financial Statements, which can be found on the company's website.
Positive
  • Publication of Half Year 2023 Financial Statements
Negative
  • None.

ObsEva Files half Year 2023 Financial Statements

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange

Geneva, SwitzerlandSeptember 27, 2023ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today published its Half Year 2023 Financial Statements. The Half Year 2023 Financial Statements may be found on the financial section of the Company’s website, here or directly via the link here.

About ObsEva

ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. ObsEva has established a development program focused on improving in vitro fertilization success rates. ObsEva is listed on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

For further information, please contact:

For general information:

contact@obseva.ch

For investors information:

IR@obseva.ch

###




Attachment


OBSV

NASDAQ:OBSV

OBSV Rankings

OBSV Latest News

OBSV Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link
Switzerland
Plan Les Ouates